@article{article, title  = {{Impact of donor-derived CD34 + infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT}},

 publisher = {{Springer Science and Business Media LLC}},

 url = {{}},

 year = {{2021}},

 month = {{12}},

 author = {{Czerw T and Iacobelli S and Malpassuti V and Koster L and Kröger N and Robin M and Maertens J and Chevallier P and Watz E and Poiré X and Snowden JA et al}},

 doi = {{10.1038/s41409-021-01540-2}},

 journal = {{Bone Marrow Transplantation}},

 note = {{Accessed on 2024/12/28}}}